HSPA5, a glucose-regulated protein first identified in 1974 [60], is widely recognized for its overexpression in a variety of cancers and has emerged as a prognostic biomarker of disease and predictor of infiltrating immune cells in the tumor microenvironment [61,62,63]. The gene discussed is HSPA5; the disease is cancer.